Non-alcoholic fatty liver disease (NAFLD) is currently related to a heavy socioeconomic
burden and increased incidence. Since obesity is the most prevalent risk factor for NAFLD …

Myosteatosis is highly prevalent in metabolic dysfunction‐associated steatotic liver disease
(MASLD) and could reciprocally impact liver function. Decreasing muscle fat could be …

Over the past 40 years, the prevalence of obesity has risen dramatically, reaching epidemic
proportions. By 2030 the number of people affected by obesity will reach 1.12 billion …

(1) Background: Bariatric surgery has demonstrated the capacity to improve metabolic-
associated fatty liver disease (MAFLD) in patients with morbid obesity. In addition, the …

Type 2 diabetes affects more than 450 million people worldwide 1 and is a leading cause of
death due to increased risk of cardiovascular, liver, and kidney disease, as well as …

A high-fat diet increases the risk of insulin resistance, type-2 diabetes, and non-alcoholic
steato-hepatitis. Here we identified two heat-shock proteins, Heat-Shock-Protein70 and …

Over the past 40 years, the prevalence of obesity has risen dramatically, reaching epidemic
proportions. Metabolic surgery has proven to be highly effective in treating obesity, leading …

Nonalcoholic fatty liver disease (NAFLD) can be harmful to the body to varying degrees, and
over a prolonged period, patients may develop steatotic cirrhosis or even develop liver …

Bariatric surgery including duodenal-jejunal bypass surgery (DJB) improves insulin
sensitivity and reduces obesity-associated inflammation. However, the underlying …

Modern changes in diet and lifestyle have led to an explosion of insulin resistance and
metabolic diseases around the globe which, if left unchecked, will become a principal driver …